ICD-10 Coding for Renal Cell Carcinoma(C64.1, C64.1B, C64.1M)
Comprehensive guide to ICD-10 coding for renal cell carcinoma, including code ranges, documentation requirements, and common pitfalls.
Complete code families applicable to Renal Cell Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis | Use when documentation specifies right kidney involvement. |
|
| C64.2 | Malignant neoplasm of left kidney, except renal pelvis | Use when documentation specifies left kidney involvement. |
|
| C64.9 | Malignant neoplasm of unspecified kidney, except renal pelvis | Use when laterality is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutRenal Cell Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Renal Cell Carcinoma.
Failing to document histologic subtype of RCC.
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Increased risk of audits and compliance issues., Financial: Potential for reduced reimbursement.
Mitigation
Ensure pathology reports specify histologic subtype.
Coding renal cell carcinoma without specifying laterality.
Impact
Reimbursement: Potential for reduced reimbursement due to unspecified coding., Compliance: Increased audit risk and potential compliance issues., Data Quality: Decreased data quality and specificity.
Mitigation
Query the provider for laterality to ensure accurate coding.
Unspecified Laterality
Impact
High audit risk due to unspecified laterality in renal cell carcinoma coding.
Mitigation
Ensure documentation specifies laterality in all cases.